Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Healthcare Biotechnology
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results

Business Wire December 17, 2018

Covalon Announces Successful Completion of Operational Integration of AquaGuard Acquisition amid Continued Business Progress

Business Wire October 30, 2018

Covalon to Showcase AquaGuard® and IV Clear™ Products to Over 9,000 Nurses at Prestigious ANCC Magnet Conference

Business Wire October 24, 2018

Covalon Announces Closing of AquaGuard Acquisition Combining Covalon’s Rich Technology Portfolio with AquaGuard’s Excellent Products and Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

Business Wire October 1, 2018

Covalon Announces Issuance of Stock Options

Business Wire September 28, 2018

Covalon to Host Conference Call to Discuss Definitive Agreement to Acquire AquaGuard

Business Wire September 20, 2018

Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

Business Wire September 20, 2018

Covalon to Showcase IV Clear at AVA Scientific Meeting 2018

Business Wire September 14, 2018

Covalon Announces Another Milestone Quarterly Profit on Excellent Third Quarter Financial Results

Business Wire August 28, 2018

Covalon Announces Receipt of First Payment Under New License Agreement

Business Wire August 20, 2018

Covalon Announces Major Banking Milestone

Business Wire August 9, 2018

Covalon Unaware of Any Material Change

Business Wire August 7, 2018

Covalon Announces Retirement of Member of Board of Directors

Business Wire July 26, 2018

Covalon Technologies Ltd. to Exhibit at the Largest Annual Infection Prevention and Control Conference in the World

Business Wire June 12, 2018

Covalon Announces Major Corporate Initiatives and Second Quarter Results

Business Wire May 28, 2018

Covalon to Host Conference Call to Discuss Release of Q2 Results and Initiatives

Business Wire May 28, 2018

Covalon Provides Further Information Regarding Estimated $100 Million Competitive Contract Awards

Business Wire May 22, 2018

Covalon Announces Major Sales Breakthrough – Wins Contracts with an Estimated Value of $100 Million Over a Three-Year Period

Business Wire May 7, 2018

Covalon to Showcase MediClear™ PreOp at AATS 2018 Annual Meeting

Business Wire April 30, 2018

New Clinical Data for Covalon’s ColActive® Line of Patented Advanced Wound Care Products to be Presented at SAWC Spring

Business Wire April 26, 2018